People: Collegium Pharmaceutical Inc (COLL.OQ)
20 Aug 2019
Mr. Scott Dreyer is Executive Vice President and Chief Commercial Officer of the company. Mr. Dreyer has served as our Executive Vice President and Chief Commercial Officer since August 2018, and joined us in January 2018 as Senior Vice President, Sales, Marketing and Training. Prior to joining us, Mr. Dreyer served as the Senior Vice President, Sales, Marketing and Commercial Operations at The Medicines Company, a biopharmaceutical company, from September 2016 to December 2017; Vice President and Chief Marketing Officer – US at Biogen from June 2014 to September 2016; and Vice President, Business Development at Publicis Touchpoint Solutions, a healthcare commercialization company, from October 2013 to June 2014. Mr. Dreyer began his career in the pharmaceutical industry at Merck & Co., where he held roles of increasing responsibility from 1994 to 2013, including Vice President of Hospital and Oncology Sales from 2011 to 2012, and Vice President of Primary Care Sales from 2012 until 2013. Mr. Dreyer holds a B.S. in Biology from Messiah College in 1994.
|Total Annual Compensation, USD||356,692|
|Restricted Stock Award, USD||307,858|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,312,360|
|Fiscal Year Total, USD||1,976,910|